1-9 of 9
Laurence Gérard
Close
Sort by
Journal Articles

KSHV/HHV-8 Associated Multicentric Castleman Disease in 80 HIV Negative Patients

Romain Stemmler, Marion Malphettes, Lionel Galicier, Laurence Gerard, Veronique Meignin, David Boutboul, Eric Oksenhendler
Journal: Blood
Blood (2023) 142 (Supplement 1): 3412.
https://doi.org/10.1182/blood-2023-181542
Published: 2023
Journal Articles

Primary Effusion Lymphoma Prognostic Score (PEL-PS): A Validated International Prognostic Score in HIV-Associated Primary Effusion Lymphoma

Kathryn Lurain, Ramya Ramaswami, Eric Oksenhendler, David Boutboul, Alessia Dalla Pria, Lara Ulrich, Krithika Shanmugasundaram, Thomas S. Uldrick, Mark Bower, Robert Yarchoan, Seth M. Steinberg, Laurence Gerard
Journal: Blood
Blood (2023) 142 (Supplement 1): 985.
https://doi.org/10.1182/blood-2023-179175
Published: 2023
Journal Articles

Higher Rate of Relapse of KSHV/HHV-8 Associated Multicentric Castleman Disease after Rituximab Therapy in HIV- Patients Than in HIV+ Patients

Eric Oksenhendler, Camille Rasmussen, David Boutboul, Lionel Galicier, Laurence Gérard
Journal: Blood
Blood (2022) 140 (Supplement 1): 7206–7207.
https://doi.org/10.1182/blood-2022-163175
Published: 2022
Journal Articles

Clinical and Biological Features Of Multiple Myeloma (MM) and Monoclonal Gammopathies In Patients With Human Immunodeficiency Virus (HIV) Infection

Alexis Talbot, MD, Laurence Gérard, MD, Raphael Szalat, MD, David Boutboul, Stephanie Harel, MD, Anne Lazareth, Marion Malphettes, MD, PhD, Bouchra Asli, MD, Lionel Galicier, MD, Claire Fieschi, MD, PhD, Eric Oksenhendler, MD, Jean Paul Fermand, MD, Bertrand Arnulf, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 5348.
https://doi.org/10.1182/blood.V122.21.5348.5348
Published: 2013
Journal Articles

Rituximab decreases the risk of lymphoma in patients with HIV-associated multicentric Castleman disease

Clinical Trials & Observations
Laurence Gérard, Jean-Marie Michot, Sara Burcheri, Claire Fieschi, Pacale Longuet, Véronique Delcey, Véronique Meignin, Felix Agbalika, Sylvie Chevret, Eric Oksenhendler, Lionel Galicier
Journal: Blood
Blood (2012) 119 (10): 2228–2233.
https://doi.org/10.1182/blood-2011-08-376012
Published: 2012
Journal Articles

HIV-Associated Non-Hodgkin Lymphoma in 114 Patients with Undetectable HIV Viral Load at NHL Diagnosis.

Eric Oksenhendler, MD, Laurence Gerard, MD, Lionel Galicier, MD, Nicolas Leturque, MD, Anne Janin, MD, PhD, Veronique Meignin, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 1578.
https://doi.org/10.1182/blood.V110.11.1578.1578
Published: 2007
Journal Articles

Intensive chemotherapy regimen (LMB86) for St Jude stage IV AIDS-related Burkitt lymphoma/leukemia: a prospective study

Clinical Trials & Observations
Lionel Galicier, Claire Fieschi, Raphael Borie, Véronique Meignin, Marie-Thérèse Daniel, Laurence Gérard, Eric Oksenhendler
Journal: Blood
Blood (2007) 110 (8): 2846–2854.
https://doi.org/10.1182/blood-2006-10-051771
Published: 2007
Journal Articles

Intensive Chemotherapy (LMB-86 Regimen) for AIDS-Related Burkitt’s Lymphoma/Leukemia.

Lionel Galicier, MD, Claire Fieschi, MD, Laurence Gerard, MD, Sylvie Chevrey, MD, Emmanuelle Boulanger, MD, Marie-Therese Daniel, MD, Veronique Meignin, MD, Eric Oksenhendler, MD
Journal: Blood
Blood (2005) 106 (11): 924.
https://doi.org/10.1182/blood.V106.11.924.924
Published: 2005
Journal Articles

Prognostic Factors and Outcome of Human Herpesvirus 8 (KSHV/HHV-8)-Associated Primary Effusion Lymphoma (PEL) in Patients with AIDS.

Emmanuelle Boulanger, Laurence Gerard, Jean Gabarre, Jean-Michel Molina, Christophe Rapp, Jean-Francois Abino, Jacques Cadranel, Sylvie Chevret, Eric Oksenhendler
Journal: Blood
Blood (2004) 104 (11): 2286.
https://doi.org/10.1182/blood.V104.11.2286.2286
Published: 2004